"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."
Pierre Jaïs, M.D. Professor of Cardiology,
Haut-Lévêque Hospital, Bordeaux, France
"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."
Dr. Wilber Su Cavanaugh Heart Center, Phoenix, AZ
"Your book [Beat Your A-Fib] is the quintessential most important guide not only for the individual experiencing atrial fibrillation and his family, but also for primary physicians, and cardiologists."
Jane-Alexandra Krehbiel, nurse, blogger and author "Rational Preparedness: A Primer to Preparedness"
"Steve Ryan's summaries of the Boston A-Fib Symposium are terrific. Steve has the ability to synthesize and communicate accurately in clear and simple terms the essence of complex subjects. This is an exceptional skill and a great service to patients with atrial fibrillation."
Dr. Jeremy Ruskin of Mass. General Hospital and Harvard Medical School
"I love your [A-fib.com] website, Patti and Steve! An excellent resource for anybody seeking credible science on atrial fibrillation plus compelling real-life stories from others living with A-Fib. Congratulations…"
Carolyn Thomas, blogger and heart attack survivor; MyHeartSisters.org
"Steve, your website was so helpful. Thank you! After two ablations I am now A-fib free. You are a great help to a lot of people, keep up the good work."
Terry Traver, former A-Fib patient
"If you want to do some research on AF go to A-Fib.com by Steve Ryan, this site was a big help to me, and helped me be free of AF."
Roy Salmon Patient, A-Fib Free; pacemakerclub.com, Sept. 2013
Realize there are others who have been through A-Fib. Find them, use them as part of your A-Fib support system.
Online support groups can be very helpful to patients and others interested in A-Fib. It’s helpful to know you are not alone. Many, many others are dealing with Atrial Fibrillation.
These groups are free, but usually require registration before you can post messages or even read the messages. All are good for posting messages and searching for responses. But each is unique. Membership numbers vary greatly.
Warning: Guard your privacy!If you join any of the online A-Fib Discussion Groups or Forums. you may want to not use your real name, address, etc.
Because insurance companies, employers, mortgage lenders, credit card companies, etc. may put your name into a search engine, i.e., ‘Google’. They may find you belong to an Atrial Fibrillation discussion site, forum, or that you have Atrial Fibrillation.
This information may be used against you or may influence their decision-making about you.
Online support groups can be very helpful to patients and others interested in A-Fib. These groups are free, but usually require registration before you can post messages or even read the messages.
If you join any of the online A-Fib Discussion Groups. you may want to not use your real name, address, etc.
Insurance companies, employers, mortgage lenders, credit card companies, etc. may ‘Google’ you and find you belong to an Atrial Fibrillation site or have A-Fib. This may influence their decision-making about you.
An alphabetical list of the journal articles, research papers, and other references cited on this website. Online links are provided and the Digital Object Identifier (DOI), when possible. (The DOI for a document is permanent and provides more stable linking than simply referring to it by its URL.)
Note: We only list online references if they are readily available. To access some research and journal articles online, the website may require you to register for a FREE account (i.e. Healthwire/Heart.org and Medscape.com).
Last updated: Thursday, February 9, 2017
Abdon NJ et al. “Is occult atrial disorder a frequent cause of non-hemorrhagic stroke? Long term ECG in 86 patients.” Stroke. 1982; 13: 832-837.
About arrhythmias and heart failure. Research Fact Sheet. British Acupuncture Council 06 August 2014 Last accessed Dec 9 2014. URL: http://www.acupuncture.org.uk/a-to-z-of-conditions/a-to-z-of-conditions/4008-arrhytmias-and-heart-failure.html
ACC/AHA/ESC. 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Circulation, 2006;114:700-752.
Acupuncture: What You Need To Know. U.S. National Center for Complementary and Alternative Medicine (NCCAM) http://nccam.nih.gov/health/acupuncture/introduction
Adams Jr., H. How To Avoid Stroke. The Good Life. Boardroom Inc., 2001, p. 31.
AHA/ACC/HRS. 2014 Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014; 130: e199-e267 DOI: 10.1161/CIR.0000000000000041.
Alcohol May Trigger Serious Palpitations in Heart Patients. American Journal of Cardiology (August 1, 2012) http://www.newswise.com/articles/alcohol-may-trigger-serious-palpitations-in-heart-patients
Allessie, M. Pathophysiology and Prevention of Atrial Fibrillation. Circulation. 2001;103(5):769.
Alpert, M. A. “Medical Cardioversion of Atrial Fibrillation” Chest 2000;117:1529-1531,
Al-Saady, N M, Obel, O A, Camm, A J.Left atrial appendage: structure, function, and role in thromboembolism. Heart 1999;82:547-554 doi:10.1136/hrt.82.5.547 http://heart.bmj.com/content/82/5/547#sthash.RSudCN96.dpuf
Atrial Fibrillation Treatment options. The London AF Centre. Last accessed November 5, 2012 http://www.londonafcentre.co.uk/atrial_fibrillation_treatment/
Atrial Fibrillation What is Atrial Fibrillation: FAQ, Un. of Utah Health Sciences. Last accessed Oct. 31, 2012. Last accessed Oct. 31, 2012. URL: http://healthsciences.utah.edu/carma/forthepatient/faqs.html
AtriCure’s AtriClip system receives FDA 510(k) clearance (press release). June 14, 2010.
Atwood, J. “Exercise Hemodynamics of Atrial Fibrillation,” Atrial Fibrillation: Mechanisms and Management, 2nd ed., edited by R. H. Falk and P. J. Podrid. Lippincott-Raven Publishers, Philadelphia, 1997: p. 222.
Banchs, Javier E., et al. Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. Journal of Interventional Cardiac Electrophysiology November 2008, Volume 23, Issue 2, pp 111-115 Last accessed March 13, 2014 URL: http://link.springer.com/article/10.1007/s10840-008-9290-6
Benchmarks for training in traditional / complementary and alternative medicine. Benchmarks for Training in Naturopathy. World Health Organization. 2010. Last accessed Dec 8 2014. URL: http://apps.who.int/medicinedocs/documents/s17553en/s17553en.pdf
Bunch, J. J., Weiss, P. P., & Crandall, B. G. et al. Atrial fibrillation is independently associated with senile, vascular, and alzheimer’s dementia. Heart rhythm, 2010:7 (4), 433-437. URL http://dx.doi.org/10.1016/j.hrthm.2009.12.004
Calkins, H, Berger, R. Atrial Fibrillation: Management Strategies. Scientific American Special Health Reports. Last accessed August 24, 2015. URL: http://tinyurl.com/Calkins-A-Fib-Mgmt-strategies
Calkins, H. Clinical Research: Heart Rhythm Disorders: Editorial. J Am Coll Cardiol. 2012;60(1):62-63. doi:10.1016/j.jacc.2012.01.068
Calkins, H. et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, March 2012, Volume 33, Issue 2, pp 171-257
Calkins, H. et al. “Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections.” Circulation, Vol. 84, 2376-2382, 1991.
Camm AJ, “Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management.” Journal of Interventional Cardiac Electrophysiology 4, 369-382, 2000, p. 373-377.
Camm AJ, “Stroke in atrial fibrillation: Update on pathology, new antithrombotic therapies, and evolution of procedures and devices.” Annals of Medicine, 39:5, 371-391, 2007
Camm AJ, et al. “Clinical efficacy and safety of vernakalant compared with amiodarone for intravenous conversion of recent onset atrial fibrillation.” Heart Rhythm Society 2010 Scientific Sessions; May 14, 2010; Denver, CO.
Cardiovascular Research, (2011) 90 (2): 220-223. Last accessed Jan 10, 2013 URL: http://cardiovascres.oxfordjournals.org/content/90/2/220.abstract
Carter, D. Treating Atrial Fibrillation and Decreasing Risk Naturally. Naturopathic Doctor News & Review (NDNR) Oct 1, 2011. http://ndnr.com/cardiopulmonary-medicine/treating-atrial-fibrillation-and-decreasing-risk-naturally/ –
Catheter Ablation for AF. The London AF Centre. Last accessed November 5, 2012 http://www.londonafcentre.co.uk/catheter_ablation/
Centers for Disease Control and Prevention, National Center for Health Statistics. Multiple Cause of Death File 1999-2004. CDC WONDER. Series 20 No. 2J, 2007. Accessed at http://wonder.cdc.gov/mcd-icd10.html on Sep. 25, 2009.
Chen, SA et al. “Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999;100:1879-1886.
Chong, BH et al. “Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events.” Europace (European Society of Cardiology) (2012) 14, 942-947. http://www.ncbi.nlm.nih.gov/pubmed/22183750 doi: 10.1093/europace/eur389
Connolly, S.J. et al. RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51. Last accessed July 10, 2014 URL:
Coumel P. “Role of the autonomic nervous system in paroxysmal atrial fibrillation.” In: Touboul P, Walso AL, eds. Atrial Arrhythmias: Current Concepts and Management. St. Louis, Mo: Mosby-Year Book; 1990:248-261.
Council on Naturopathic Medical Education (CNME), http://www.cnme.org/index.html
Cox, J. L. “The Role of Surgical Intervention in the Management of Atrial Fibrillation,” Texas Heart Institute Journal, 2004; 31 (3): 257-265.
Crawford, R. A New Perspective on Iron Deficiency. Presentation at NIH Workshop, June 2001in Bethesda, MD Iron Overload Diseases Association.
Crayhon, R The Carnitine Miracle. M. Evans and Company, Inc. April 14, 1998.
Cui YQ et al. “Video-assisted minimally invasive surgery for lone atrial fibrillation: a clinical report of 81 cases.” Journal of Thoracic and Cardiovascular Surgery 1 February 2010 Volume 139, issue 2, Pages 326-332.
Dabek, J. et al. “Cardioversion and atrial stunning,” Pol Merkur Lekarski. 2007 Mar;22(129):224-8. PMID: 17682682
Damiano, Jr, R. et al. “The Cox-Maze IV procedure for lone atrial fibrillation.” Multimedia Manual of Cardiothoracic Surgery. MMCTS (July 23, 2007).
Damiano, Jr., RJ. “What Is the Best Way to Surgically Eliminate the Left Atrial Appendage?” Journal of the American College of Cardiology 2008, Sept. 9; Vol. 52, No. 11:930-1.
Day JD et al. “Atrial Fibrillation significantly reduces long-term mortality and strokes in a large patient population.” Heart Rhythm Society 2010 Scientific Sessions; May 14, 2010; Denver, CO.
Day JD et al. “Catheter ablation of atrial fibrillation reduces the risk of Alzheimer’s disease and dementia.” Heart Rhythm Society 2010 Scientific Sessions; May 13, 2010; Denver, CO
Day, John. Letter from the Editor in Chief. The Journal of Innovations in Cardiac Rhythm Management, 5 (2014), A6-A7. Last accessed May 15, 2014, URL: http://www.innovationsincrm.com/cardiac-rhythm-management/2014/may/586-letter-from-the-editor-in-chief
Dernellis, J.M., “Relationship between C-reactive protein concentrations during glucorticoid therapy and recurrent atrial fibrillation.” Eur. Heart J. 2004;25: 1100-1107. doi:10.1001/archinte.1987.00370090041008.
Deshmukh, A. et al. In-Hospital Complications Associated with Catheter Ablation of AF in US: 2000-2010. Analysis of 93,801 Procedures.
Drug treatment for Atrial Fibrillation. The London AF Centre. Last accessed November 8, 2012. http://www.londonafcentre.co.uk/drugs_for_af/
Eby G, et al. Elimination of cardiac arrhythmias using oral taurine with l-arginine with case histories: Hypothesis for nitric oxide stabilization of the sinus node. Med Hypotheses. 2006;67(5):1200-4. Epub 2006 Jun 23. PubMed PMID: 16797868. Lasted accessed March 2, 2013. URL: http://www.ncbi.nlm.nih.gov/pubmed/16797868
Efstathopoulos, EP. et al. “Patient and staff radiation dosimetry during cardiac electrophysiology studies and catheter ablation procedures: a comprehensive analysis.” Europace (The European Society of Cardiology), 2006 8(6): 443-448; doi:10.1093/europace/eul041
Ehrlich, S. D. (2011, June 16). Magnesium. University of Maryland Medical Center/Medical Reference/Complementary Medicine. Last accessed November 5, 2012, from http://www.umm.edu/altmed/articles/magnesium-000313.htm
Elayi, S. C. “Better treatment for atrial fibrillation.” Bottom Line Health, September 2013, p. 13.
Elias, M. F. Atrial Fibrillation Is Associated With Lower Cognitive Performance in the Framingham Offspring Men.” Journal of Stroke and Cerebrovascular Diseases, Vol. 15, No. 5 (September-October), 2006: pp. 214-222. Last accessed 10-31-2012. URL http://www.strokejournal.org/article/S1052-3057(06)00075-9/abstract
Even, Dan. “Israeli scientists discover the heart’s hidden healing cells.” HAERETZ, May 7, 2013 http://www.haaretz.com/news/national/israeli-scientists-discover-the-heart-s-hidden-healing-cells.premium-1.519585
Falk R. “Atrial Fibrillation.” New England Journal of Medicine, Vol. 344, No. 14; April 5, 2001, p. 1071-1074.
Faloon, William. Life Extension. January 2014, p. 9.
FDA Exposed: An Interview With Dr. David Graham, the Vioxx Whistleblower. Life Extension, October 2012, P. 72.
Fein, A.S. et al. Treatment of Obstructive Sleep Apnea Reduces the Risk of Atrial Fibrillation Recurrence After Catheter Ablation. J Am Coll Cardiol. Vol. 62, No. 4, 2013;62:300-5. http://dx.doi.org/10.1016/j.jacc.2013.03.052.
Feinberg, W. M. “Epidemiological features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation.” Arch Intern Med 1990;150:2340-2344.
Feinberg, W. M. “Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications.” Arch Intern Med 1995;155:469-473.
Garcia-Fernandez, Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis. Journal of American College of Cardiology 2003;42(7):1253-1258. doi:10.1016/S0735-1097(03)00954-9
Gillinov A M, Blackstone EH, et al. “Atrial Fibrillation: Current surgical options and their assessment.” Ann. Thorac. Surg. 2002; 74:2210-17.
Go, A.S, Hylek, E.M, Phillips, K. A, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375. URL http://dx.doi.org/10.1001/jama.285.18.2370
Goodman, Dennis. This Mineral Prevents Headaches, Heart Disease, More. Bottom Line Personal. Volume 35, Number 2, January 15, 2014.
Gorman, C, “A Candidate’s Racing Heart,” TIME, Sunday, Dec. 12, 1999.
Gotto, Jr., Antonio M. Bottom Line Health Newsletter, Vol 26 November 2012, p. 4.
Griffin, R. Morgan. Exercise and Atrial Fibrillation. WebMD. http://www.webmd.com/heart-disease/atrial-fibrillation/features/exercises-heart-health But I disagree with WebMD’s use of a statement from Dr. Gordon F. Tomaselli of Johns Hopkins, “It’s very possible to live a normal life (in A-Fib) for many years.” Leaving someone in A-Fib for many years overworks the heart and leads to remodeling and fibrosis which increase stroke risk and contribute to eventual heart failure. See Drug Therapies. (WebMD is owned and operated in part by the drug company Eli Lily.)
Grimm, RA et al. “Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography.” J Am Coll Cardiol. 1993 Nov 1;22(5):1359-66. PMID 8227792
Grosser, Tilo. “Coated-aspirin alert.” Bottom Line Health. Volume 27 Number 4, April, 2013, p. 1.
Guasch-Ferre, MM et al. Dietary magnesium intake is inversely associated with mortality in adults at high cardiovascular risk. J Nutr. 2014 January;144(1):55-60. http://jn.nutrition.org/content/early/2013/11/20/jn.113.183012
Gupta, D. “AF: Ablation or Drugs” Heart Rhythm Specialist. Last accessed November 5, 2012http://www.heartrhythmspecialist.co.uk/Heartrhythmspecialist.co.uk/Welcome.html
Haines D. “Atrial Fibrillation: New Approaches in Management.” Un. of Virginia multi-media presentation, 1999.
Haissaguerre, M, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol (1994)5:1045–1052.
Haïssaguerre, M. “Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci,” Circulation. 2000;101:p. 1409.
Haïssaguerre, M. et al. “Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias.” Journal of Cardiovascular Electrophysiology, Vol. 16, November 2005, pp. 1138-47.
Haïssaguerre, M et al. “Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.” New England Journal of Medicine. 1998;339;659-666.
Han, F.T. et al. Heart Rhythm, “Minimally invasive surgical atrial fibrillation ablation: Patient selection and results.” Vol 6, No 12S, December Supplement 2009, P. 575.
Hansson A, Madsen-Hardig B, Olsson SB. Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: a study based on interviews with 100 patients seeking hospital assistance. BMC Cardiovasc Disord. 2004; 4: 13.
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society. 2007. Last accessed Oct. 31,2012. URL: http://www.ncbi.nlm.nih.gov/pubmed/17599941 2012 update DOI: 10.1093/europace/eus027
HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Journal of Interventional Cardiac Electrophysiology, March 2012, Volume 33, Issue 2, pp 171-257
Hsu, Li-Fern et al. “Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure.” N Eng J Med 2004; 351:2373-2383 Last accessed November 5, 2012 http://www.nejm.org/doi/full/10.1056/NEJMoa041018
Jacob, E. MEDIFOCUS Atrial Fibrillation, “Anticoagulants for Stroke Prevention in People with Atrial Fibrillation.” 2009, p. 3.
Jais, P. et al. Ablation therapy for atrial fibrillation (AF) Past, present and future. Cardiovascular Research, Vol. 54, Issue 2, May 2002, P. 343. http://cardiovascres.oxfordjournals.org/content/54/2/337.abstract?sid=ad903e5c-bfbf-4720-8651-262b35547ac5
Jaïs, P. NASPE Convention Presentation, San Diego, CA, May 8, 2002.
James, John. Survive your stay at the hospital—Medical errors are linked to 440,000 deaths each year. Consumer Reports, May 2014.
Jessurun, G. and Crijns, H. “Amiodarone pulmonary toxicity―Dose and duration of treatment are not the only determinants of toxicity.” BMJ, 1997, Volume 314, Number 7081, 619. Last accessed Jan 10, 2013 URL: http://www.bmj.com/content/314/7081/619.full
Kaarisalo, M. M. et al. Atrial Fibrillation and Stroke: Mortality and Causes of Death After the First Acute Ischemic Stroke. Stroke. 1997; 28: 311-315 DOI: 10.1161/01.STR.28.2.311
Kaneko, T & Aranki, S. F. Hybrid Surgical and Catheter Treatment for Atrial Fibrillation. ISRN Cardiology, Volume 2013, Article ID 920635. .
Karasoy, D., et al. Obesity triggers AF in fertile women. 2012 ESC Congress/Munich. Press release of 26 Aug 2012 Presentation. European Society of Cardiology. Last accessed March 5, 2013. URL: http://tinyurl.com/Obesity-triggers-AF.
Khan AM, Lubitz SA, Sullivan LM, et al. Low serum magnesium and the development of atrial fibrillation in the community: The Framingham Heart Study. Circulation 2012; DOI 10.1161/CirculationAHA.111.082511
Kim TH et al. Acupuncture treatment for cardiac arrhythmias: A systematic review of randomized controlled trials. Am J Cardiol 2011; 149(2):263-5. doi: 10.1016/j.ijcard.2011.02.049. Last accessed Dec 9 2014. URL: http://www.ncbi.nlm.nih.gov/pubmed/21421272
Kim, M. H., Johnston, S. S., Chu, B.-C., et al. (2011). Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circulation: Cardiovascular Quality and Outcomes. URL http://dx.doi.org/10.1161/CIRCOUTCOMES.110.958165
Kiser, A C. Advantages of the Convergent Procedure UNC Cardiac Surgery and Electrophysiology Services, Last accessed November 5, 2012 from http://acati.org/advantages.htm
Kron, J. et al. Heart Rhythm, “Management of Recurrent Atrial Arrhythmias After Minimally Invasive Surgical Pulmonary Vein Isolation and Ganglionic Plexi Ablation for Atrial Fibrillation.” Vo. 7, No 4, April 2010, p. 445-451.
Lakkireddy D, et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol. 2013 Mar 19;61(11):1177-82. doi: 10.1016/j.jacc.2012.11.060. Epub 2013 Jan 30. PubMed PMID: 23375926. Last accessed Dec 9, 2014. URL: http://www.ncbi.nlm.nih.gov/pubmed/23375926
Lakkireddy, D. et al. “Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation.” Journal of the American College of Cardiology, Vol. 59, Issue 13, March 2012, pp. 1168-1174. doi:10.1016/j.jacc.2011.12.014. http://content.onlinejacc.org/article.aspx?articleid=1206384
Leinonen, Jussi V. et al. “Left Atrial Appendages from Adult Hearts Contain a Reservoir of Diverse Cardiac Progenitor Cells.” PLOS ONE, 8(3): e59288. doi: 10.1371/journal.pone.0059228. http://www.plosone.org/article/info:doi/10.1371/journal.pone.0059228
Li, Christopher. Antihypypertensive medications and Breast Cancer risk. JAMA Internal Medicine. 2013 Sept. 23; 173(17):1629-37. http://www.ncbi.nlm.nih.gov/pubmed/23921840. doi: 10.1001/jamainternmed.2013.9071.
Li, Christopher. Blood pressure medication may increase risk for breast cancer. Bottom Line Personal. Volume 35, Number 2, January 15, 2014.
Lim SH, et al. Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage. Ann Emerg Med. January 1998;31:30–5
Linkins, L. A. et al. “Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism. A Meta-Analysis.” Annals of Internal Medicine, Dec. 2003.
Lip, G. Atrial Fibrillation in Practice. London. Royal Society of Medicine Press, 2002.
Lip, G. et al. “ABCs of antithrombotic therapy: antithrombotic therapy for Atrial Fibrillation.” BMJ. (2002), 325, 7371, 1022-1025.
Lloyd-Jones, D.M., Epidemiology and Treatment of Atrial Fibrillation: What Is AF? Medscape Education. Last accessed November 5, 2012
Lombardi F, et al. Acupuncture for paroxysmal and persistent atrial fibrillation: An effective non-pharmacological tool? World J Cardiol 2012; 4(3): 60-65. doi: 10.4330/wjc.v4.i3.60. Last accessed Dec 9 2014. URL: http://www.wjgnet.com/1949-8462/full/v4/i3/60.htm
Lomuscio A, et al. Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion. J Cardiovasc Electrophysiol. 2011 Mar;22(3):241-7. doi: 10.1111/j.1540-8167.2010.01878.x. Last accessed Dec 9 2014. URL: http://www.ncbi.nlm.nih.gov/pubmed/20807278?report=docsum&format=text
Lomuscio, A et al. “Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion.” Journal of Cardiovascular Electrophysiology, August 30, 2010 (Epub ahead of print) Last accessed Jan 10, 2013 URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312232/
Loren, K., Rapid Heart Beat and High Blood Pressure: The Route to Improvement. Last accessed November 5, 2012.
Los Angeles Times, November 27, 2007, p. A14.
Lowes, R. Dronedarone makes FDA watch list five straight times. July 19, 2011. Heartwire,TheHeart.org. Last accessed November 6, 2012
Lowry, F. Calcium supplements boost heart-attack risk: Meta-analysis. August 3, 2010. Heartwire, TheHeart.org. Last accessed November 5, 2012.
Lucille, Holly (DrHollyLucille.com) Natural remedy for anxiety Bottom Line Health. April 2014, p. 16.
Macle, L et al. “Radiation Exposure During Radiofrequency Catheter Ablation for Atrial Fibrillation.” Pacing and Clinical Electrophysiology, March 28, 2003. Volume 26, Issue 1p2, Pages 288-291.
Mandrola, J. (2012, August 28). ESC 2012: Surgical AF ablation at the time of cardiac surgery. . . . Should we fix it while in there? [Web log post]. Last accessed November 5, 2012, from
Mandrola, J. (2012, August 4). The changing role of rhythm-control medicines for AF [Web log post]. Last accessed November 5, 2012, from
Mandrola, J. “A year-end review of 2012: Top stories in EP. theHeart.org, Jan 2, 2013. Last accessed Jan 24, 2013 URL
Mandrola, J. Choosing wisely: The electrophysiology list of five don’ts. Apr 9, 2012. Last accessed Jan 25, 2013, URL: http://blogs.theheart.org/trials-and-fibrillations-with-dr-john-mandrola/2012/4/9/choosing-wisely
Mandrola, John. Atrial Flutter–15 facts you may want to know. in AF Ablation, Atrial Fibrillation. August 5, 2013.
Manolis, Antonia S. “More Bleeding With the Newer Anticonagulants?” RHYTHMOS , Volume 7, No 2, (26) April, 2012. Last accessed Jan. 24, 2013, URL: http://www.rhythmos.gr/index.php/Rhythmos/article/view/123/122
Mantovan R, et al. “Comparison Between Anatomical and Integrated Approaches to Atrial Fibrillation: Adjunctive Role of Electrical Pulmonary Vein Disconnection.”Journal of Cardiovascular Electrophysiology. Vol. 16, December, 2005. pp. 1293-1297.
Martins, RP et al. Dominant Frequency Increase Rate Predicts Transition from Paroxysmal to Long-Term Persistent Atrial Fibrillation. Circulation, published online January 24, 2014. http://www.ncbi.nlm.nih.gov/pubmed/24463369
Maugh II, T. H. “New drugs may replace problematic blood thinner.” Los Angeles Times, Tuesday, November 16, 2010, p. A12.
MediFocus Guide “Atrial Fibrillation.” #CR004, July 10, 2009.
Mercola, J. Over 60 Billion Doses a Year and Not ONE Death, But Still Not Safe? April 23, 2012. Last accessed April 1, 2013. URL: http://articles.mercola.com/sites/articles/archive/2012/04/23/defend-your-right-to-access-safe-dietary-supplements.aspx
MyHealthNewsDaily February 08, 2013. Last accessed Nov 5, 2014. URL: http://www.livescience.com/26965-marijuana-smoking-stroke-risk.html
Nainggolan, L. Half of all AF due to avoidable risk factors. March 29, 2011 Heartwire, TheHeart.org. Last accessed November 9, 2012
Nainggolan, L. Net clinical benefit of warfarin in AF is highest in prior stroke victims and the very old. September 1, 2009. Heartwire, TheHeart.org. Last accessed November 6, 2012.
Nainggolan, L. Blacks more likely to have AF than previously thought? May 6, 2009. Heartwire, TheHeart.org. Last accessed November 6, 2012
Nainggolan, L. Cryoablation: Safer than RF but slightly lower success rate? June 23 2008. Heartwire,TheHeart.org. Last accessed November 6, 2012.
Nair, M. et al. “Safety and Efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.” J. Am. Board Fam Med, 2011 Jan-Feb; 24(1): 86-92. DOI: 10.3122/jabfm.2011.01.080096
Narayan, S. M. et al. “Clinical Mapping Approach to Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial Fibrillation.” Journal of Cardiovascular Electrophysiology. 2012 May;23(5): 447-54 http://www.ncbi.nlm.nih.gov/pubmed/22537106 doi: 10.1111/j.1540-8167.2012.02332.x
Narayan, S. M. et al. Computational Mapping Identifies Localized Mechanisms for Ablation of Atrial Fibrillation.” PloS One. 2102: 7(9): e46034. http://www.plosone.org/article/info. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458823/ doi:10.1371/journal.pone.0046034
Natale, A. “First Human Experience With Pulmonary Vein Isolation Using a Through-the-Balloon Circumferential Ultrasound Ablation System for Recurrent Atrial Fibrillation,” Circulation. 2000;102:pp.1879-1882.
National Survey.” Academic Medicine, 85(9): 1537-1542. Last accessed Dec 1 2014. URL: http://tinyurl.com/drs-lack-nutrition-training
Navarrete, A. et al. “Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit.” Journal of Cardiovascular Electrophysiology, July 19, 2010 (Epub ahead of print)
Navas, Sandra. “Continuing Professional Development—Cardiology, Atrial fibrillation: part 2.” NS194 (2003) Nursing Standard. 17. 38, 47-54. Last accessed November 6, 2012. http://nursingstandard.rcnpublishing.co.uk/archive/article-atrial-fibrillation-part-2
Nayab A, “Conversion of Atrial Flutter to sinus rhythm by carotid sinus pressure.” Journal of the National Medical Association, Vol. 74, NO. 8, 1982.
Neel, A B. Are Your Prescriptions Killing You? Bottom Line Personal, Vol 34, No. 1. January 1, 2013, p. 9.
Nelson, B. “Places In the Heart,” NYU Physician. Spring, 2009, p. 8. Last accessed November 05, 2012, from http://communications.med.nyu.edu/publications/nyu-physician/spring-2009
No Deaths From Vitamins: America’s Largest Database Confirms Supplement Safety. Orthomolecular Medicine News Service, December 28, 2011; Last accessed April 1, 2013. URL: http://orthomolecular.org/resources/omns/v07n16.shtml
O’Riordan, M. Acute Coronary Syndromes: More bleeding, no extra ischemic protection with high-dose aspirin in HORIZONS-AMI trial. Heartwire/theHeart.org. December 19, 2012. Last accessed Dec. 30, 2012.
O’Riordan, M. RECORD AF: Better Success With Rhythm Control, But No Difference in Outcomes. Heartwire/Medscape Medical News. November 17, 2009. Last accessed March 29, 2014. URL:
O’Riordan, Michael. “Cardiac stem cells improve LV function, reduce infarct size in ischemic cardiomyopathy.” HeartWire November 22, 2011. http://www.theheart.org/article/1316341.do
Oakes, R. et al. Detection and Quantification of Left Atrial Structural Remodeling With Delayed-Enhancement Magnetic Resonance Imaging in Patients with Atrial Fibrillation. Circulation. 2009; 119:1758-1767, published online before print. March 23 2009, doi:10.1161/CIRCULATIONAHA.108.811877
Olsson S. “Atrial fibrillation – where do we stand today?” Journal of Internal Medicine. 2001;250: p. 19.
Omega-6 and Omega-3 Fatty Acids, Cardiovascular Disease Comprehensive 9 – Therapeutic D-E. Last accessed Jan 10, 2013. URL: http://www.lifeextensionvitamins.com/cadico9thde.html
Orenstein, BW. The Benefits of Yoga for Afib. Everydayhealth.com 05/30/2013. Last accessed Dec 9, 2014. URL: http://www.everydayhealth.com/health-report/atrial-fibrillation-and-stroke/yoga-for-afib.aspx
Ott, A.et al. Atrial fibrillation and dementia in a population-based study: The Rotterdam study.” Stroke 1997;28:316-321.
Paluska S A. “Caffeine and exercise.” Curr Sports Med Rep 2003;2:213-9
Pantethine Life Extension Vitamins. Last accessed November 5, 2012 http://www.lifeextensionvitamins.com/cadico13thps.html
Pappone C et al: A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation: The APAF Study. J Am Coll Cardiol 2006; 48: 2340-47. doi:10.1016/j.jacc.2006.08.037
Pappone, C. et al. “Atrial electroanatomical remodeling after circumferential radiofrequency pulmonary vein ablation. Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation.” Circulation 2001;104:2539-2544.
Pappone, C. et al. “Circumferential Pulmonary Vein Ablation for Atrial Fibrillation: the Milan Experience,” Cardiac Electrophysiology and Pacing Unit of the Department of Cardiology, San Raffaele University Hospital, Milan, Italy. 2003. p. 7.
Patel MR, et al. ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91. Last accessed July 10, 2014,
Paydek, H. “Atrial Fibrillation after Radiofrequency Ablation of Type I Atrial Flutter,” Circulation. 1998;98:p.315.
Petronis KR, Anthony JC. An epidemiologic investigation of marijuana- and cocaine-related palpitations. Drug Alcohol Depend 1989; 23: 219-26.
Podrid, P. “Oral Antiarrhythmic Drugs Used for Atrial Fibrillation: Clinical Pharmacology,” Atrial Fibrillation: Mechanisms and Management, edited by R. H. Falk and P. J. Podrid, Raven Press, Ltd., New York, 1992: p. 200.
Poli D, et al “Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.” J. Thorac Cardiovasc Surg. 2010 Feb;139(2);326-32.
Prystowsky E. “Management of Atrial Fibrillation: Therapeutic Options and Clinical Decisions,” The American Journal of Cardiology. Vol. 85 (10A), May 25, 2000, p. 5D.
Prystowsky, E. “Should atrial fibrillation ablation be considered first-line therapy for some patients?” Circulation 2005;112:1214-1231, p. 1228.
Prystowsky, E. Atrio-esophageal fistula, thus far reported only after circumferential pulmonary vein ablations, may be related to the more extensive ablation lesions applied to the posterior left atrium.” “AF Ablation as First-Line Therapy.” Circulation 2005;112:1214-1231, p. 1227.
Ramanathan, C. at al. (and Yoram Rudy). “Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia.” Nature Medicine 10, 422-428 , March 14, 2004. Doi:10.1038/nm1011.
Roby’s Arrhythmia Story. Publsihed on MyFastHeartBeat.com Last accessed November 5, 2012.
Romano, M. A. et al.Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery. Ann Thorac Surg 2004;77:1282-1287. Last accessed Aug 24, 2015. URL: http://www.ncbi.nlm.nih.gov/pubmed/15063252
Rosenberg, Martha. “Grassley Investigates Lilly/WebMD link Reported by Washington Post.” OpEnNews.com, 2/24/2010. http://www.opednews.com/articles/Grassley-Investigates-Lill-by-Martha-Rosenberg-100224-629.html
Rosengren, M. A. et al. “Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men.” Eur Heart J 2009; DOI:10.1093/eurheart/ehp084.
Roukoz H, Saliba W (January 2007). “Dofetilide: a new class III antiarrhythmic agent”. Expert Rev Cardiovasc Ther 5 (1): 9–19. doi:10.1586/14779072.5.1.9. PMID 17187453
Ryan, S. S. Dr. Douglas Packer of the Mayo Clinic in Rochester, MN discussed “Surgical and Catheter-Based Strategies for Stroke Prevention in A-Fib”. A-Fib.com Boston A-Fib Symposium 2006 Summaries. Last accessed November 10, 2012
Sacher, F. et al. Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study.” Journal of American Cardiology, 2006 Jun 20; 47(12): pp. 2498-503.
Scheinman M. “Nonpharmacological Approaches to Atrial Fibrillation,” Circulation. 2001:103: p. 2120.
Schmidt, B. et al. Feasibility of Circumferential Pulmonary Vein Isolation Using a Novel Endoscopic Ablation System. Circ Arrhythm Elcetrophysiol published online Jul 24 2010. Last accessed Jan 11, 2013. http://www.cardiofocus.com/pdf/Schmidt_CircEP_Laser.pdf DOI: 10.1161/CIRCEP.110.954149
Schouchoff, B. “Surgical Approaches for Atrial Fibrillation.” Critical Care Nursing Quarterly July/September 2007, Volume 30, Number 3, Pages 233-242. Last accessed Oct. 31,2012. URL:http://www.afibmaze.com/p4.html
Schuchert A et al. “Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after acute ischemic stroke.” Pacing Clin Electrophyiol. 1999′ 22″ 1082-1084.
Seet RC, Zhang Y, Wijdicks EF, Rabinstein AA. Relationship between chronic atrial fibrillation and worse outcomes in stroke patients after intravenous thrombolysis. Arch Neurol. 2011 Nov;68(11):1454-8. doi: 10.1001/archneurol.2011.248. PubMed PMID: 22084129. URL: http://www.ncbi.nlm.nih.gov/pubmed/22084129.
Seven Reasons to Use BCAA Supplements. Invigorate360.com Last accessed Jan 10, 2013 URL: http://www.invigorate360.com/reviews/7-reasons-to-use-bcaa-supplements/
Shallenberger, Frank. Real Cures, August 2014, Vol. 13, No. 8.
Shapira, A. R., “Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation.” American Family Physician, November 15, 2009, p. 1089. Last accessed Oct. 31,2012. URL: http://www.aafp.org/afp/2009/1115/p1089.html
Shepherd, J. et al. (2008). Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 12(28). Last accessed November 5, 2012 fromhttp://www.ncbi.nlm.nih.gov/pubmed/18547499
Sick, PB. Initial Worldwide Experience With the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Atrial Fibrillation. Figure 5. Journal of the American College of Cardiology. Volume 49, Issue 13, 3 April 2007, Pages 1490–1495. Last accessed Jan 10, 2013 URL: http://www.sciencedirect.com/science/article/pii/S0735109707007474
Sinatra, S J., “The Sinatra Solution Metabolic Cardiology.” Basic Health Publications, 2008.
Sinatra, Stephen J., “The Sinatra Solution Metabolic Cardiology.” Basic Health Publications, 2008
Singer, DE, et al. The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation. Annals of Internal Medicine, 2009 Vol 151, 5 pp297-305. Last accessed Jan 10, 2013 URL: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2777526/
Sopher, S. M et al. “Neural Aspects of Atrial Fibrillation,” in Atrial Fibrillation: Mechanisms and Management, Falk and Podrid ed., Lippincott and Raven, 1997, p. 159.
Spragg, D., et al. Role of Magnetic Resonance Imaging of Atrial Fibrosis in Atrial Fibrillation Ablation. Arrhythmia & Electrophysiology Review 2013;2(2):124-7.
Stabile G, et al: Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). European Heart Journal 2006; 27:216-221, DOI: 10.1093/eurheartj/ehi583
Steinberg J S, et al. “Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery.” Circulation, Vol. 88, 2618-2622, 1993.
Stereotaxis Announces Initial U.S. Clinical Usages of Cardiac Ablation Catheter With Company’s Niobe(R) System. 2006. Press release. Last accessed November 5, 2012 http://www.medscape.com/pages/editorial/pressreleases/pr-crm-stereotaxis4
Stevenson, IH, et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J (2008); 29 (13):1662-1669. doi: 10.1093/eurheartj/ehn214
Thuronyi, V. Vagally Mediated Paroxysmal Atrial Fibrillation–A Patient’s View. International Health News. July 2000. Last accessed Oct. 31, 2012. URL: http://www.afibbers.org/victor2.html
Tiered Approach Offers Atrial Fibrillation Patients Better Chance for Cure. Bluhm Cardiovascular Institute News Release February 15, 2011. Last accessed November 5, 2012 http://www.nmh.org/nm/atrial-fibrillation-treatments
Traber PG et al. Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease. Plus One, 2013 Oct.9;8(10):e75361 http://www.ncbi.nlm.nih.gov/pubmed/24130706; doi: 10.1371/journal.pone.0075361. eCollection 2013.
True-Hills, M. Bridging the AFib Communications Gap: An Atrial Fibrillation Patient Perspective Presentation at the Western Atrial Fibrillation Symposium, February 26, 2011. Last accessed Oct. 31,2012. URL:
Tse H-F, et al. P Wave Polarity During Pacing in Pulmonary Veins. Journal of Interventional Cardiac Electrophysiology, 2001;5:167-172. Last accessed Oct. 31,2012. URL:http://www.ingentaconnect.com/content/klu/jice/2001/00000005/00000002/00334438
Tu HT, et al. for the EPITHET-DEFUSE Investigators. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation. Int J Stroke. 2013 Mar 12. doi: 10.1111/ijs.12007. [Epub ahead of print] PubMed PMID: 23489996; PubMed Central PMCID: PMC3688700.
Turpie, AGG. New oral anticoagulants in atrial fibrillation. European Heart Journal. Volume 29, Issue 2 pp. 155-165. First pubished online. 2007. Accessed Oct. 31, 2012. URL http://eurheartj.oxfordjournals.org/content/29/2/155.short
Types of Iron Disorders. 2009 Iron Disorders Institute. Last accessed November 9, 2012 http://www.irondisorders.org/iron-disorders
U.S. National Heart, Lung and Blood Institute, http://www.nhlbi.nih.gov/index.html Atrial Fibrillation: Treatment Options, Catheter Ablation. The London AF Centre website. Last accessed March 29, 2014. URL: http://www.londonafcentre.co.uk
U.S. National Heart, Lung and Blood Institute, http://www.nhlbi.nih.gov/index.html Atrial Fibrillation: Treatment Options, Catheter Ablation. The London AF Centre website. Last accessed March 29, 2014. URL: http://www.londonafcentre.co.uk
Unda #248 Cardiovascular Insufficiencies. http://www.pureformulas.com/unda-248-20ml-by-seroyal.html Note: the formula is on the Ingredients tab for; Contains 25% alcohol;
Unda #8. Cardiovascular, Heart Meridian http://www.pureformulas.com/unda-8-20ml-by-seroyal.html Note: the formula is on the Ingredients tab for; Contains 25% alcohol;
United Nations Scientific Committee on the Effects of Atomic Radiations(UNSCEAR). Hereditary effects of ionising radiation. United Nations, New York (2001) Last accessed November 6, 2012 http://www.unscear.org/docs/reports/gareport.pdf
US Food and Drug Administration. “AtriCure Synergy Ablation System – P100046” December 15, 2011. Last accessed Jan 24, 2013. URL: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfTopic/pma/pma.cfm?num=P100046
Vitamin D Deficiency, WebMD. Retrieved October 25, 2012. URL: http://www.webmd.com/diet/vitamin-d-deficiency
Vitamin K. Wikipedia, the free encyclopedia. Last accessed April 13, 2014, URL: http://en.wikipedia.org/wiki/Vitamin_K
Wang, Paul. Hospital Offers Innovative, Hybrid Procedure for Difficult Cases of Atrial Fibrillation. Stanford Hospital & Clinics Press Release, February 14, 2011. Last accessed February 24, 2014, URL: http://stanfordhospital.org/newsEvents/newsReleases/2011/dual-ablation.html
Warriner, Cal. “The Debate Over Pradaxa (Dabigatran) Safety – Follow the Money” The Legal Examiner, West Palm Beach, Florida, March 20, 2012.Last accessed April 16, 2013. URL:http://tinyurl.com/debate-over-pradaxa
Wazni, O.M. et al: Radiofrequency Ablation vs. Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation A Randomized Trial. JAMA 2005;293(21):2634-2640. DOI:10.1001/jama.293.21.2634
Welniak, C. New Research Yields Insight into Stroke Mechanism for Atrial Fibrillation Patients. February 24, 2011 StopAfib.org. Last accessed November 5, 2012 http://www.stopafib.org/newsitem.cfm/NEWSID/317/fibrosis
What are the risks of Atrial Fibrillation? The London AF Centre. Last accessed November 6, 2012. http://www.londonafcentre.co.uk/what_are_the_risks_of_af;
Wittert, A. H. et al. Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients withFibrillation. JAMA. 2013;310(19):2050-2060. doi:10.1001/jama.2013.280521.
Wolf R, Schneeberger E, Osterday R, et al. (2005). “Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation”. J Thorac Cardiovasc Surg 130 (3): 797–802. doi:10.1016/j.jtcvs.2005.03.041. PMID16153931.
Wood, S. Dabigatran Q+A: The who, when, and how for switching, starting, and stopping the new oral anticoagulant. November 3, 2010. Heartwire, TheHeart.org. Last accessed November 6, 2012
Wyndham C. “Atrial Fibrillation the Most Common Arrhythmia.” Texas Heart Institute Journal, 2000;27,3, p. 261.
Wyse, D. G. “Atrial Fibrillation: The Clinically Relevant Trials and Results.” .
Yu J. et al. “Safety and efficacy of high-versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction.” JACC Cardiovasc Interv, 2012; 5:1231-1238. Last Accessed March 23 2013. URL: http://tinyurl.com/bntttac.
Zembala M, et al. Minimally invasive hybrid ablation procedure for the treatment of persistent atrial fibrillation: one year results. Kardiol Pol. 2012;70(8):819-28. PubMed PMID: 22933215. Last accessed Feb 22, 2014, URL: http://www.ncbi.nlm.nih.gov/pubmed/22933215
One-to-one support and online support groups can be very helpful to patients and others interested in A-Fib. First, it’s helpful to know you are not alone.
One-to-One, our A-Fib Support Volunteers are just an email away
Many, many others are dealing with Atrial Fibrillation. Second, the discussion with fellow patients can often benefit those just reading the discussion, perhaps offering a new perspective. But, don’t stay on the sideline, participate! Join in. You’ll feel better talking with others who know what you are dealing with.
These services are free. Some may require registration before you can post messages or even read the messages.
Each service is unique. Membership numbers vary greatly. Some offer useful databases of information. And while some are focused on a specific type of A-Fib, they often cover many subjects relevant to anyone with A-Fib.
Do you have a favorite discussion group not listed here? Email us, so we can add it to our list.
Warning: If you join any of these groups, you may not want to use your real name, address, etc. Insurance companies, employers, mortgage lenders, credit card companies, etc. may ‘Google’ you and find you belong to an Atrial Fibrillation site or have A-Fib. This may influence their decision-making about you.
If you find any errors on this page, email us. ♥ Last updated: Friday, October 21, 2016
We have personally picked these sites for you. We value the information they present. These online sites may be helpful when seeking additional information and research on A-Fib.
A Word of Caution: Some web sites for A-Fib patients may be biased toward a particular technique or approach, often for financial gain. When searching online always ask yourself, “Who is paying for this website, and what is their agenda?”
In alphabetical order ♥ Last updated: Thursday, February 16, 2017
A-FibFacts.Info: Resource of unbiased Atrial Fibrillation facts and statistics backed up with full research citations and sources. Useful for journalists, reporters, bloggers and educators. Sponsored by Steve S. Ryan and A-Fib.com; http://www.A-FibFacts.Info.
The AFIB Report, editor, Shannon Dickson. AFib research and information, main focus is on lone atrial fibrillation (AF with no underlying heart disease). Patient forum: A-Fibbers.org. Founded by Dick Inglis. http://www.afibbers.org/homepage.html
Atrial Fibrillation Association (AFA-UK and US): is a non-profit organization which provides information, support and access to established, new or innovative treatments for atrial fibrillation; patient advocacy and information sharing; UK branch and United States branch.
Center Watch: an information source for patients interested in participating in current clinical trial; CenterWatch is a trusted source and global destination for both professionals and patients. http://centerwatch.com
MedlinePlus:designed by U.S. NLM/NIH for consumers, containing hundreds of topic pages including videos, health check tools, drug, herb and supplement info, links to Fact Sheets from other NIH Institutes, the CDC, etc., and more; http://www.nlm.nih.gov/medlineplus/
Polar Heart Rate Monitors: Consumer (DIY) products to help you monitor your heart rate while exercising and/or while in A-Fib; Since 1977, Polar has been at the cutting edge of advanced sports technology. http://www.polar.fi/polar/channels/eng/index.html
PubMed & MEDLINE Database: over 24 million citations for biomedical literature, life science journals, and online books. Free resource of the U.S. National Library of Medicine (NLM)/National Institutes of Health (NIH); http://www.ncbi.nlm.nih.gov/pubmed/
University Hospital of Bordeaux, France, Cardiology and Electrophysiology Services: (Cardiologic Hospital of Haut-Lévêque): World leader in treatment of Atrial Fibrillation (referred to as “the Bordeaux Group”). Headed by Prof. Michel Häissaguerre (researcher, professor and inventor of PVI for A-Fib). Electrophysiology and Ablation Unit head: Prof. Pierre Jais; URL: http://tinyurl.com/The-Bordeaux-Group
Up-to-Date: review of over 350 journals for new research findings on A-Fib; very comprehensive and current; Beyond the basics, for patients, requires a subscription either weekly or monthly. URL: http://www.uptodate.com/home
A Word of Caution: Some web sites for A-Fib patients may be biased toward a particular technique or approach, often for financial gain. When searching online always ask yourself, “Who is paying for this website, and what is their agenda?”
Disclaimer: the authors of this Web site are not medical doctors and are not affiliated with any medical school or organization. The information on this site is not intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health professional prior to starting any new treatment or with any questions you may have regarding a medical condition. Nothing contained in this service is intended to be for medical diagnosis or treatment.